Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22694189 | 0.87 | CYP3A4 (0.45) | CYP3A4CYP1A2CYP2D6CYP2C9PTGS1 | |
| SCHEMBL22694219 | 0.85 | GABBR2 (0.48) | CYP1A2CYP2C9PTGS1PTGS2ALOX5 | |
| SCHEMBL22694220 | 0.85 | ALOX5 (0.52) | CYP3A4CYP1A2CYP2D6CYP2C9CYP2B6 | |
| SCHEMBL22694183 | 0.82 | CA12 (0.47) | CYP2D6CYP2C9PTGS2 | |
| SCHEMBL22694187 | 0.81 | AKR1B10 (0.48) | — | |
| SCHEMBL22694185 | 0.80 | SNCA (0.41) | CYP3A4CYP1A2CYP2D6CYP2C9PTGS1 | |
| SCHEMBL22694184 | 0.80 | AKR1B10 (0.30) | — | |
| SCHEMBL22694186 | 0.79 | EPHX2 (0.57) | CYP3A4CYP1A2CYP2D6CYP2C9CYP2B6 | |
| SCHEMBL19961454 | 0.75 | — | — | |
| SCHEMBL22694188 | 0.75 | NFKB1 (0.44) | ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200369605-A1 | ONIUM SALT, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200369605-A1 | ONIUM SALT, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | PAG1, SLC6A5, LBR | CYP3A4 4767/4885CYP1A2 4576/4885CYP2D6 3894/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.